BACKGROUND/ PURPOSE: The repair of large abdominal wall defects is still a challenge for pediatric surgeons. Synthetic materials, however, may lead to high complication rates. This study was aimed at applying tissue-engineering methods to abdominal wall repair. METHODS: 3T3 mouse fibroblasts were expanded in vitro. In the next step, a biodegradable material--polyglycolic acid (PGA)--was actively seeded with 10(7) cells/scm of PGA scaffold. Culture medium (Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum) was changed every 6 hours after seeding cells on PGA fibers. Under general anaesthesia, C57BL/6J black mice underwent creation of a 2 x 3-cm abdominal wall defect (60%-70% of abdominal surface). The defect was repaired in the experimental group with the fibroblast-seeded PGA scaffold. In the first control group, the defect was covered with acellular PGA, and in the second control group, by skin closure. Animals were killed after 30 days to assess the histologic and gross findings. RESULTS: No abdominal hernia was found in animals repaired with cell-seeded and acellular scaffolds. All animals with skin closure died within 7 days. In every case, tissue-engineered construct was thicker then in controls. Histologic and gross examination revealed a good neovascularisation in tissue-engineered abdominal walls comparing to the acellular matrix. There was no intensive scar formation between abdominal wall and skin. CONCLUSIONS: Engineered soft tissue constructs can provide structural replacement of severe and large abdominal wall defects. Tissue engineering in the near future will possibly enter clinical practice.
BACKGROUND/ PURPOSE: The repair of large abdominal wall defects is still a challenge for pediatric surgeons. Synthetic materials, however, may lead to high complication rates. This study was aimed at applying tissue-engineering methods to abdominal wall repair. METHODS: 3T3 mouse fibroblasts were expanded in vitro. In the next step, a biodegradable material--polyglycolic acid (PGA)--was actively seeded with 10(7) cells/scm of PGA scaffold. Culture medium (Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum) was changed every 6 hours after seeding cells on PGA fibers. Under general anaesthesia, C57BL/6J black mice underwent creation of a 2 x 3-cm abdominal wall defect (60%-70% of abdominal surface). The defect was repaired in the experimental group with the fibroblast-seeded PGA scaffold. In the first control group, the defect was covered with acellular PGA, and in the second control group, by skin closure. Animals were killed after 30 days to assess the histologic and gross findings. RESULTS: No abdominal hernia was found in animals repaired with cell-seeded and acellular scaffolds. All animals with skin closure died within 7 days. In every case, tissue-engineered construct was thicker then in controls. Histologic and gross examination revealed a good neovascularisation in tissue-engineered abdominal walls comparing to the acellular matrix. There was no intensive scar formation between abdominal wall and skin. CONCLUSIONS: Engineered soft tissue constructs can provide structural replacement of severe and large abdominal wall defects. Tissue engineering in the near future will possibly enter clinical practice.
Authors: Y Tsai; N Ross; H Niebuhr; M Sailer; F Köckerling; L Sun; Y M Shen; J Chen; S J Liu; F Q Chen; G Y Yang; C Berney; P Malouf; D Suarez; J L Tavera; J Ocadiz; T Chen; J Wang; R Mancini; G Pattaro; F Ceci; E Spaziani; B Bansa; P Lal; R Sharma; G Pradhan; J Chander; V K Ramteke; S Wijerathne; N Agarwal; D Liem; D Lomanto; J Warren; W Cobb; J Ewing; A Carbonell; O Guillaume; E Holl; J Park; X Monforte; H Redl; A Petter-Puchner; S Gruber-Blum; A Teuschl; E Yoshihara; H Pottel; M D'Hondt; P Jadhav; T Nagahama; M Ando; K Ami; H Amagasa; H Ganno; K Arai; M Kitamura; K El-Hayek; J Yoo; M Phillips; E Pauli; J Bittner; M Kroh; D Garcia; T Furtado; L Alberti; C Neto; P Hubner; A Alves; C Oliveira; J Vianna; C Campolina; G Dumanian; Z Dumanian; A Tulaimat; S Chen; L J Liu; A Guttadauro; S Frassani; D Macchini; A Bertolini; M Maternini; F Gabrielli; V Subramanian; D Venditti; A De Majo; G Sena; G Lisi; F De Sanctis; G Petrella; A Porwal; M Jadhav; M Stein; L Kaveggia; J Clift; W Noda; H Niebuhr; N Ross; H Niebuhr; N Ross; H Niebuhr; N Ross; H Niebuhr; N Ross; H Niebuhr Journal: Hernia Date: 2015-04 Impact factor: 4.739
Authors: O Guillaume; J Park; X Monforte; S Gruber-Blum; H Redl; A Petter-Puchner; A H Teuschl Journal: J Mater Sci Mater Med Date: 2015-12-24 Impact factor: 3.896
Authors: Antonio D'Amore; Marco Fazzari; Hong-Bin Jiang; Samuel K Luketich; Michael E Luketich; Richard Hoff; Daniel L Jacobs; Xinzhu Gu; Stephen F Badylak; Bruce A Freeman; William R Wagner Journal: Tissue Eng Part A Date: 2018-02-27 Impact factor: 3.845
Authors: C Moreno-Sanz; M Manzanera-Díaz; F J Cortina-Oliva; J de Pedro-Conal; M Clerveus; J Picazo-Yeste Journal: Tech Coloproctol Date: 2011-09-29 Impact factor: 3.781
Authors: Maciej Nowacki; Arkadiusz Jundziłł; Łukasz Nazarewski; Andrzej Kotela; Tomasz Kloskowski; Joanna Skopińska-Wisniewska; Magdalena Bodnar; Aleksander Łukasiewicz; Sławomir Nazarewski; Ireneusz Kotela; Marek Kucharzewski; Marta Pokrywczyńska; Andrzej Marszałek; Tomasz Drewa Journal: Biomed Res Int Date: 2015-02-05 Impact factor: 3.411